MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,053,476 | +1682.8% | 75,688 | +2720.0% | 0.04% | +1750.0% |
Q2 2023 | $620,004 | -42.3% | 2,684 | -83.8% | 0.00% | 0.0% |
Q3 2022 | $1,075,000 | +98.7% | 16,534 | +118.7% | 0.00% | +100.0% |
Q2 2022 | $541,000 | +452.0% | 7,559 | +513.1% | 0.00% | – |
Q3 2021 | $98,000 | -24.6% | 1,233 | -7.5% | 0.00% | – |
Q2 2021 | $130,000 | +19.3% | 1,333 | +42.9% | 0.00% | – |
Q1 2021 | $109,000 | -70.0% | 933 | -71.4% | 0.00% | -100.0% |
Q4 2020 | $363,000 | -16.0% | 3,265 | -10.2% | 0.00% | 0.0% |
Q3 2020 | $432,000 | +2600.0% | 3,637 | +2554.7% | 0.00% | – |
Q2 2020 | $16,000 | -88.9% | 137 | -91.8% | 0.00% | -100.0% |
Q3 2019 | $144,000 | +80.0% | 1,666 | +117.5% | 0.00% | 0.0% |
Q2 2019 | $80,000 | +7900.0% | 766 | +10842.9% | 0.00% | – |
Q1 2019 | $1,000 | -95.7% | 7 | -99.6% | 0.00% | – |
Q3 2016 | $23,000 | – | 1,824 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |